Free tool
Oncology stocks
We cover 4 companies grouped under the Oncology theme. The median market value in the group is $142.35B. Across the group, the median move over the past trading day is +2.63%. Price change over the past year runs from −6.1% to +76.3% across the middle 80 percent of the group, with a median of +23.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.